186 related articles for article (PubMed ID: 26448540)
1. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
[TBL] [Abstract][Full Text] [Related]
2. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
[TBL] [Abstract][Full Text] [Related]
3. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
4. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
[TBL] [Abstract][Full Text] [Related]
5. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
[TBL] [Abstract][Full Text] [Related]
6. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
Priebe S; Yeeles K; Bremner S; Lauber C; Eldridge S; Ashby D; David AS; O'Connell N; Forrest A; Burns T
BMJ; 2013 Oct; 347():f5847. PubMed ID: 24100934
[TBL] [Abstract][Full Text] [Related]
8. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.
Noordraven EL; Audier CH; Staring AB; Wierdsma AI; Blanken P; van der Hoorn BE; Roijen LH; Mulder CL
BMC Psychiatry; 2014 Dec; 14():343. PubMed ID: 25438877
[TBL] [Abstract][Full Text] [Related]
9. Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.
Noordraven EL; Schermer MHN; Blanken P; Mulder CL; Wierdsma AI
BMC Psychiatry; 2017 Aug; 17(1):313. PubMed ID: 28851345
[TBL] [Abstract][Full Text] [Related]
10. The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time?
Pavlickova H; Bremner SA; Priebe S
J Clin Psychiatry; 2015 Aug; 76(8):e1029-34. PubMed ID: 26335089
[TBL] [Abstract][Full Text] [Related]
11. [Payment for accepting depot medication].
Mulder CL; Noordraven E; Staring AB
Ned Tijdschr Geneeskd; 2014; 158(4):A7309. PubMed ID: 24447676
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
[TBL] [Abstract][Full Text] [Related]
13. Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?
Moran K; Priebe S
Qual Life Res; 2016 Aug; 25(8):1897-902. PubMed ID: 26850023
[TBL] [Abstract][Full Text] [Related]
14. Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication.
Moncrieff J; Azam K; Johnson S; Marston L; Morant N; Darton K; Wood N
BMC Psychiatry; 2016 Jul; 16():205. PubMed ID: 27377549
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.
Rosenheck RA; Leslie DL; Sindelar JL; Miller EA; Tariot PN; Dagerman KS; Davis SM; Lebowitz BD; Rabins P; Hsiao JK; Lieberman JA; Schneider LS;
Arch Gen Psychiatry; 2007 Nov; 64(11):1259-68. PubMed ID: 17984395
[TBL] [Abstract][Full Text] [Related]
16. Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness.
García-Pérez L; Linertová R; Serrano-Pérez P; Trujillo-Martín M; Rodríguez-Rodríguez L; Valcárcel-Nazco C; Del Pino-Sedeño T
Int J Psychiatry Clin Pract; 2020 Nov; 24(4):416-427. PubMed ID: 32609024
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of offering an area-level financial incentive on breast feeding: a within-cluster randomised controlled trial analysis.
Anokye N; Coyle K; Relton C; Walters S; Strong M; Fox-Rushby J
Arch Dis Child; 2020 Feb; 105(2):155-159. PubMed ID: 31444210
[TBL] [Abstract][Full Text] [Related]
18. Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial.
Priebe S; Bremner SA; Pavlickova H
BMJ Open; 2016 Sep; 6(9):e011673. PubMed ID: 27655261
[TBL] [Abstract][Full Text] [Related]
19. Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.
Staring AB; Mulder CL; Priebe S
Psychopharmacol Bull; 2010; 43(1):5-10. PubMed ID: 20581796
[TBL] [Abstract][Full Text] [Related]
20. Offering financial incentives to increase adherence to antipsychotic medication: the clinician experience.
Highton-Williamson E; Barnicot K; Kareem T; Priebe S
J Clin Psychopharmacol; 2015 Apr; 35(2):120-7. PubMed ID: 25692797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
